Since IL-6 has already been shown to be associated with pathogenic mechanisms of MG [29], we decided to focus on the IL-6 pathway involvement and the common downstream actor of IL-6 and IGF1 pathways Akt/PKB. Here, IGF1 is linked to myasthenia gravis.